Previous Article | Next Article 
Molecular and Cellular Biology, November 2003, p. 8070-8083, Vol. 23, No. 22
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.22.8070-8083.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
I
B Kinase-Independent I
B
Degradation Pathway: Functional NF-
B Activity and Implications for Cancer Therapy
Vinay Tergaonkar, Virginie Bottero, Masahito Ikawa,
Qiutang Li, and Inder M. Verma*
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037
Received 22 April 2003/
Returned for modification 7 July 2003/
Accepted 9 August 2003
Antiapoptotic activity of NF-
B in tumors contributes to acquisition of resistance to chemotherapy. Degradation of I
B is a seminal step in activation of NF-
B. The I
B kinases, IKK1 and IKK2, have been implicated in both I
B degradation and subsequent modifications of NF
B. Using mouse embryo fibroblasts (MEFs) devoid of both IKK1 and IKK2 genes (IKK1/2-/-), we document a novel I
B degradation mechanism. We show that this degradation induced by a chemotherapeutic agent, doxorubicin (DoxR), does not require the classical serine 32 and 36 phosphorylation or the PEST domain of I
B
. Degradation of I
B
is partially blocked by phosphatidylinositol 3-kinase inhibitor LY294002 and is mediated by the proteasome. Free NF-
B generated by DoxR-induced I
B degradation in IKK1/2-/- cells is able to activate chromatin based NF-
B reporter gene and expression of the endogenous target gene, I
B
. These results also imply that modification of NF-
B by IKK1 or IKK2 either prior or subsequent to its release from I
B is not essential for NF-
B-mediated gene expression at least in response to DNA damage. In addition, DoxR-induced cell death in IKK1/2-/- MEFs is enhanced by simultaneous inhibition of NF-
B activation by blocking the proteasome activity. These results reveal an additional pathway of activating NF-
B during the course of anticancer therapy and provide a mechanistic basis for the observation that proteasome inhibitors could be used as adjuvants in chemotherapy.
* Corresponding author. Mailing address: Laboratory of Genetics, The Salk Institute for Biological Studies, 10010 North Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 453-4100. Fax: (858) 558-7454. E-mail:
verma{at}salk.edu.
Present address: Genome Information Research Center, Osaka University, 3-1, Yamadaoka, Suita, Osaka 565-0871, Japan.
Molecular and Cellular Biology, November 2003, p. 8070-8083, Vol. 23, No. 22
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.22.8070-8083.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bednarski, B. K., Ding, X., Coombe, K., Baldwin, A. S., Kim, H. J.
(2008). Active roles for inhibitory {kappa}B kinases {alpha} and {beta} in nuclear factor-{kappa}B-mediated chemoresistance to doxorubicin. Molecular Cancer Therapeutics
7: 1827-1835
[Abstract]
[Full Text]
-
Khong, T., Sharkey, J., Spencer, A.
(2008). The effect of azacitidine on interleukin-6 signaling and nuclear factor-{kappa}B activation and its in vitro and in vivo activity against multiple myeloma. haematol
93: 860-869
[Abstract]
[Full Text]
-
Biswas, G., Tang, W., Sondheimer, N., Guha, M., Bansal, S., Avadhani, N. G.
(2008). A Distinctive Physiological Role for I{kappa}B{beta} in the Propagation of Mitochondrial Respiratory Stress Signaling. J. Biol. Chem.
283: 12586-12594
[Abstract]
[Full Text]
-
Huang, R. S., Duan, S., Kistner, E. O., Bleibel, W. K., Delaney, S. M., Fackenthal, D. L., Das, S., Dolan, M. E.
(2008). Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity. Cancer Res.
68: 3161-3168
[Abstract]
[Full Text]
-
Greve, B., Weissert, R., Hamdi, N., Bettelli, E., Sobel, R. A., Coyle, A., Kuchroo, V. K., Rajewsky, K., Schmidt-Supprian, M.
(2007). I{kappa}B Kinase 2/beta Deficiency Controls Expansion of Autoreactive T Cells and Suppresses Experimental Autoimmune Encephalomyelitis. J. Immunol.
179: 179-185
[Abstract]
[Full Text]
-
Izzo, J. G., Malhotra, U., Wu, T.-T., Luthra, R., Correa, A. M., Swisher, S. G., Hofstetter, W., Chao, K.S. C., Hung, M.-C., Ajani, J. A.
(2007). Clinical Biology of Esophageal Adenocarcinoma after Surgery Is Influenced by Nuclear Factor-{kappa}B Expression. Cancer Epidemiol. Biomarkers Prev.
16: 1200-1205
[Abstract]
[Full Text]
-
Ahn, K. S., Sethi, G., Aggarwal, B. B.
(2007). Simvastatin Potentiates TNF-{alpha}-Induced Apoptosis through the Down-Regulation of NF-{kappa}B-Dependent Antiapoptotic Gene Products: Role of I{kappa}B{alpha} Kinase and TGF-beta-Activated Kinase-1. J. Immunol.
178: 2507-2516
[Abstract]
[Full Text]
-
Morais, C., Pat, B., Gobe, G., Johnson, D. W., Healy, H.
(2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol Dial Transplant
21: 3377-3388
[Abstract]
[Full Text]
-
Park, S.-S., Kim, J.-M., Kim, D.-S., Kim, I.-H., Kim, S.-Y.
(2006). Transglutaminase 2 Mediates Polymer Formation of I-{kappa}B{alpha} through C-terminal Glutamine Cluster. J. Biol. Chem.
281: 34965-34972
[Abstract]
[Full Text]
-
Horiguchi, K., Arai, S., Nishihara, T., Nishikawa, J.-i.
(2006). AIB1 Promotes DNA Replication by JNK Repression and AKT Activation during Cellular Stress. J Biochem
140: 409-419
[Abstract]
[Full Text]
-
Dolcet, X., Llobet, D., Encinas, M., Pallares, J., Cabero, A., Schoenenberger, J. A., Comella, J. X., Matias-Guiu, X.
(2006). Proteasome Inhibitors Induce Death but Activate NF-{kappa}B on Endometrial Carcinoma Cell Lines and Primary Culture Explants. J. Biol. Chem.
281: 22118-22130
[Abstract]
[Full Text]
-
Ralstin, M. C., Gage, E. A., Yip-Schneider, M. T., Klein, P. J., Wiebke, E. A., Schmidt, C. M.
(2006). Parthenolide Cooperates with NS398 to Inhibit Growth of Human Hepatocellular Carcinoma Cells through Effects on Apoptosis and G0-G1 Cell Cycle Arrest. Mol Cancer Res
4: 387-399
[Abstract]
[Full Text]
-
Lu, H., Ouyang, W., Huang, C.
(2006). Inflammation, a Key Event in Cancer Development. Mol Cancer Res
4: 221-233
[Abstract]
[Full Text]
-
Izzo, J. G., Malhotra, U., Wu, T.-T., Ensor, J., Luthra, R., Lee, J. H., Swisher, S. G., Liao, Z., Chao, K.S. C., Hittelman, W. N., Aggarwal, B. B., Ajani, J. A.
(2006). Association of Activated Transcription Factor Nuclear Factor {kappa}B With Chemoradiation Resistance and Poor Outcome in Esophageal Carcinoma. JCO
24: 748-754
[Abstract]
[Full Text]
-
Li, Q., Lu, Q., Bottero, V., Estepa, G., Morrison, L., Mercurio, F., Verma, I. M.
(2005). Enhanced NF-{kappa}B activation and cellular function in macrophages lacking I{kappa}B kinase 1 (IKK1). Proc. Natl. Acad. Sci. USA
102: 12425-12430
[Abstract]
[Full Text]
-
Newcomb, E. W., Ali, M. A., Schnee, T., Lan, L., Lukyanov, Y., Fowkes, M., Miller, D. C., Zagzag, D.
(2005). Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1{alpha} expression in human glioma cells by a proteasome-independent pathway: Implications for in vivo therapy. Neuro Oncol Duke
7: 225-235
[Abstract]
-
Massa, P. E., Li, X., Hanidu, A., Siamas, J., Pariali, M., Pareja, J., Savitt, A. G., Catron, K. M., Li, J., Marcu, K. B.
(2005). Gene Expression Profiling in Conjunction with Physiological Rescues of IKK{alpha}-null Cells with Wild Type or Mutant IKK{alpha} Reveals Distinct Classes of IKK{alpha}/NF-{kappa}B-dependent Genes. J. Biol. Chem.
280: 14057-14069
[Abstract]
[Full Text]
-
Buss, H., Dorrie, A., Schmitz, M. L., Hoffmann, E., Resch, K., Kracht, M.
(2004). Constitutive and Interleukin-1-inducible Phosphorylation of p65 NF-{kappa}B at Serine 536 Is Mediated by Multiple Protein Kinases Including I{kappa}B Kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF Family Member-associated (TANK)-binding Kinase 1 (TBK1), and an Unknown Kinase and Couples p65 to TATA-binding Protein-associated Factor II31-mediated Interleukin-8 Transcription. J. Biol. Chem.
279: 55633-55643
[Abstract]
[Full Text]
-
Hayden, M. S., Ghosh, S.
(2004). Signaling to NF-{kappa}B. Genes Dev.
18: 2195-2224
[Abstract]
[Full Text]
-
Biswas, D. K., Shi, Q., Baily, S., Strickland, I., Ghosh, S., Pardee, A. B., Iglehart, J. D.
(2004). NF-{kappa}B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. USA
101: 10137-10142
[Abstract]
[Full Text]
-
Bohuslav, J., Chen, L.-f., Kwon, H., Mu, Y., Greene, W. C.
(2004). p53 Induces NF-{kappa}B Activation by an I{kappa}B Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1. J. Biol. Chem.
279: 26115-26125
[Abstract]
[Full Text]
-
Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., Kuo, M.-L.
(2004). Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation. J. Biol. Chem.
279: 24015-24023
[Abstract]
[Full Text]
-
Veiby, O. P., Read, M. A.
(2004). Chemoresistance: Impact of Nuclear Factor (NF)-{kappa}B Inhibition by Small Interfering RNA: Commentary re J. Guo et al., Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-{kappa}B p65 Subunit. Clin Cancer Res 2004;10:3333-3341. Clin. Cancer Res.
10: 3262-3264
[Full Text]